DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells

被引:0
|
作者
Yegor Smurnyy
Mi Cai
Hua Wu
Elizabeth McWhinnie
John A Tallarico
Yi Yang
Yan Feng
机构
[1] Developmental and Molecular Pathways,
[2] Novartis Institutes for Biomedical Research,undefined
来源
Nature Chemical Biology | 2014年 / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Drug-resistance mutations provide a classical means to identify biological targets of small molecules. A combination of next-generation DNA sequencing with CRISPR-Cas9 genome editing confirms the targets of 6-thioguanine and triptolide and offers a general approach for target identification in cells.[graphic not available: see fulltext]
引用
收藏
页码:623 / 625
页数:2
相关论文
共 50 条
  • [31] Assessing Off-Target Editing of CRISPR-Cas9 Systems
    Pruett-Miller, Shondra M.
    CRISPR JOURNAL, 2020, 3 (06): : 430 - 432
  • [32] Battling CRISPR-Cas9 off-target genome editing
    Daisy Li
    Hong Zhou
    Xiao Zeng
    Cell Biology and Toxicology, 2019, 35 : 403 - 406
  • [33] Battling CRISPR-Cas9 off-target genome editing
    Li, Daisy
    Zhou, Hong
    Zeng, Xiao
    CELL BIOLOGY AND TOXICOLOGY, 2019, 35 (05) : 403 - 406
  • [34] gRNA validation for wheat genome editing with the CRISPR-Cas9 system
    Taj Arndell
    Niharika Sharma
    Peter Langridge
    Ute Baumann
    Nathan S. Watson-Haigh
    Ryan Whitford
    BMC Biotechnology, 19
  • [35] CRISPR-Cas9: A tool for rapid target discovery and validation
    Wiggins, Ceri M.
    Walter, David
    Russell, Paul
    Sheridan, Clare
    Hudson, Chantelle
    Yarker, Joanne
    le Sage, Carlos
    McCarthy, Nicola
    Moore, Jonathan D.
    CANCER RESEARCH, 2018, 78 (13)
  • [36] CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells
    Kim, Eun Ji
    Kang, Ki Ho
    Ju, Ji Hyeon
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (01): : 42 - 61
  • [37] Off-target predictions in CRISPR-Cas9 gene editing using deep learning
    Lin, Jiecong
    Wong, Ka-Chun
    BIOINFORMATICS, 2018, 34 (17) : 656 - 663
  • [38] Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells
    Molugu, Kaivalya
    Khajanchi, Namita
    Lazzarotto, Cicera R.
    Tsai, Shengdar Q.
    Saha, Krishanu
    CRISPR JOURNAL, 2023, 6 (05): : 473 - 485
  • [39] Modular Crispr-Cas9 Ribonucleoprotein Complexes For Precise Gene Editing Of Human Cells
    Saha, K.
    Carlson-Stevermer, J.
    Abdeen, A.
    Kohlenberg, L.
    Goedland, M.
    Molugu, K.
    Lou, M.
    TISSUE ENGINEERING PART A, 2017, 23 : S38 - S38
  • [40] RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells
    Rouatbi, Nadia
    Walters, Adam A.
    Costa, Pedro M.
    Qin, Yue
    Liam-Or, Revadee
    Grant, Vivien
    Pollard, Steven M.
    Wang, Julie Tzu-Wen
    Al-Jamal, Khuloud T.
    JOURNAL OF CONTROLLED RELEASE, 2024, 375 : 776 - 787